[Calcitonin gene-related peptide (CGRP)]

Area of Science:

• Neuroendocrinology
• Cardiovascular Physiology
• Molecular Biology

Background:

• Calcitonin gene-related peptide (CGRP) is a 37 amino acid peptide derived from calcitonin gene products.
• While calcitonin is the primary product in thyroid C cells, CGRP predominates in the nervous system.
• CGRP is widely distributed and recognized as a key neuromediator, especially within the cardiovascular system.

Purpose of the Study:

• To explore the physiological roles and potential therapeutic applications of CGRP.
• To investigate CGRP's involvement in cardiovascular regulation, blood pressure modulation, and various pathological conditions.
• To understand CGRP's broader effects on glucose metabolism, endocrine functions, and organ systems.

Main Methods:

• Review of existing literature on CGRP discovery, gene expression, and physiological effects.
• Analysis of studies investigating CGRP's impact on cardiovascular parameters like vasodilation and blood pressure.
• Examination of research linking CGRP levels to conditions such as hypertension, septic shock, and Raynaud's syndrome.

Main Results:

• CGRP is a potent endogenous vasodilator, influencing blood flow distribution and potentially modulating blood pressure.
• CGRP levels are altered in conditions like hypertension (decreased) and septic shock (increased).
• CGRP shows potential in treating conditions including severe Raynaud syndrome, erectile dysfunction, and heart failure.

Conclusions:

• CGRP is a significant neuromediator with diverse physiological functions, particularly in the cardiovascular system.
• Dysregulation of CGRP is implicated in various pathological states, suggesting its role in disease pathogenesis.
• CGRP holds promise as a therapeutic agent for several clinical conditions, warranting further investigation.